Uncover key drivers, emerging technologies, and competitive movements shaping the cell-based ophthalmic therapies market from 2025–2034 with trusted insights from The Business Research Company
What Are The Future Growth Projections For The Cell-Based Ophthalmic Therapies Market Size?
The market size for cell-based ophthalmic therapies has witnessed substantial growth in recent years. This market is anticipated to expand from $1.22 billion in 2024 to $1.48 billion in 2025, at a compound annual growth rate (CAGR) of 21.1%. The historical growth of this market is attributable to the rising prevalence of eye disorders, increasing demand for vision restoration, growing adoption of regenerative medicine, rising cases of age-related degeneration, and increasing clinical trial investments.
The cell-based ophthalmic therapies market is anticipated to experience substantial expansion over the next few years. It is projected to achieve a size of $3.14 billion by 2029, growing at a compound annual growth rate (CAGR) of 20.7%. This growth during the forecast period is primarily driven by the increasing success of cell therapies, rising global healthcare spending, an expanding geriatric patient population, a growing range of innovative products in development, and the wider application of stem cells. Key trends expected in the coming years include advancements in stem cell and gene editing technologies, the development of specialized drug delivery systems, innovations in regenerative medicine to restore retinal and corneal tissues, progress in biomaterials to enhance cell therapy efficacy and safety, and the establishment of global collaborations.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27246&type=smp
Which Factors Are Steering Growth In The Cell-Based Ophthalmic Therapies Market?
The cell-based ophthalmic therapies market is expected to grow due to the increasing prevalence of ophthalmic disorders. These disorders are defined as conditions or diseases that impact the eyes, causing vision problems or harm to eye health. The rise in ophthalmic disorders is linked to the aging population, which faces a greater susceptibility to age-related eye diseases, leading to vision impairment with longer life expectancies. Cell-based ophthalmic therapies function by repairing or replacing damaged retinal and eye cells to reinstate vision and avert further deterioration, while also encouraging regeneration and enhancing overall eye function. For instance, in September 2023, data from the Association of Optometrists, a UK-based representative membership organization, showed that England recorded 22,552 new vision impairment certifications in 2022, comprising 1,344 from diabetic eye disease, 3,614 from glaucoma, and 10,865 from age-related macular degeneration. Thus, the escalating incidence of ophthalmic disorders is driving the growth of the cell-based ophthalmic therapies market.
How Is The Cell-Based Ophthalmic Therapies Market Organized By Different Segments?
The cell-based ophthalmic therapies market covered in this report is segmented
1) By Therapy Type: Stem Cell Therapy, Gene Therapy, Tissue Engineering
2) By Application: Retinal Disorders, Corneal Disorders, Glaucoma, Other Applications
3) By End-User: Hospitals, Ophthalmic Clinics, Research Institutes, Other End-Users
Subsegment:
1) By Stem Cell Therapy: Embryonic Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Retinal Pigment Epithelium Cell Therapy, Limbal Stem Cell Therapy
2) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Vector Based Gene Therapy, In-Vivo Gene Therapy, Ex-Vivo Gene Therapy, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Gene Therapy
3) By Tissue Engineering: Bioengineered Corneal Tissue, Amniotic Membrane Transplantation, Hydrogel-Based Scaffolds, Synthetic Polymer Scaffolds, Decellularized Tissue Constructs
What Current And Upcoming Trends Are Shaping The Cell-Based Ophthalmic Therapies Market?
Companies operating in the cell-based ophthalmic therapies market are primarily focused on creating advanced treatments, such as allogeneic cell therapy, to meet the existing unmet needs in managing corneal endothelial diseases. Allogeneic cell therapy is a treatment method that employs stem cells or other cells contributed by a genetically distinct individual of the same species to repair or substitute damaged tissues or treat ailments. For instance, in September 2024, Aurion Biotech, Inc., a US-based clinical-stage biotechnology company, announced the commercial launch of Vyznova (neltependocel) in Japan. This treatment is formulated for bullous keratopathy, a debilitating condition impacting the corneal endothelium. Vyznova is considered to be the first approved allogeneic cell therapy specifically addressing corneal endothelial disease, having successfully obtained both regulatory and reimbursement approvals in Japan.
Who Are The Most Influential Companies In The Cell-Based Ophthalmic Therapies Market?
Major companies operating in the cell-based ophthalmic therapies market are F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Astellas Pharma Inc., Sumitomo Pharma Co. Ltd., Healios K.K., Lineage Cell Therapeutics, Pandorum Technologies Pvt. Ltd., ActualEyes Inc., Neurotech Pharmaceuticals Inc., Coave Therapeutics SAS, jCyte Inc., Eyestem Research Pvt. Ltd., Opsis Therapeutics, Regenerative Patch Technologies LLC, Emmetrope Ophthalmics LLC, GenSight Biologics S.A., MEDIPOST Co. Ltd., Riken, Luxa Biotechnology Inc.
Access The Complete Report Here:
Which Region Dominates The Cell-Based Ophthalmic Therapies Market Today?
North America was the largest region in the cell-based ophthalmic therapies market in 2024. The regions covered in the cell-based ophthalmic therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=27246&type=smp
Browse Through More Reports Similar to the Global Cell-Based Ophthalmic Therapies Market 2025, By The Business Research Company
Wooden Interior Door Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/wooden-interior-door-global-market-report
Aluminum Doors And Windows Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/aluminum-doors-and-windows-global-market-report
Commercial Overhead Doors Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/commercial-overhead-doors-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
